High interest rates will reduce investment in pharma contract manufacturers
Pharmaceutical Technology
FEBRUARY 24, 2023
During a time when increasingly innovative biologics are being approved and pharma companies are seeking contractors to mitigate the risk of supply chain disruptions, the long-term effects of slowing investment could significantly hinder global pharma manufacturing.
Let's personalize your content